Extension Study for 2993-112
Completed · Phase 3
Conditions studied: Type 2 Diabetes Mellitus
In brief
This multicenter, open-label extension study of Protocol 2993-112 is designed to assess long-term glucose control as measured by HbA1c (glycosylated hemoglobin) and to evaluate long-term safety and tolerability in subjects treated with metformin who receive subcutaneously injected AC2993 (10 mcg) administered twice daily. Subjects completing Protocol 2993-112 are eligible to enroll.
Key facts
- Study ID
- NCT01789957
- Run by
- AstraZeneca
- People needed
- 225
- Starts
- 2002-09-01
- Expected to finish
- 2004-06-01
- Last updated by the study team
- 2015-02-24
Who can join
Age: 16 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Parkway Medical Center — Birmingham, Alabama, United States
- Alabama Clinical Therapeutics — Birmingham, Alabama, United States
- Eclectic Family Care — Eclectic, Alabama, United States
- Winston Physician Services — Haleyville, Alabama, United States
- Simon Williamson Clinic — Hueytown, Alabama, United States
- Extended Arm Physicians/ Southern Drug — Montgomery, Alabama, United States
- Southern Drug Research Network — Tallassee, Alabama, United States
- Mesa Center for Clinical Research — Chandler, Arizona, United States
- Clinic of Physicians and Surgeons, Ltd. — Mesa, Arizona, United States
- ANA Ventures, LLC — Mesa, Arizona, United States
- Lovelace Scientific Resources — Phoenix, Arizona, United States
- Physicians at the Peak — Phoenix, Arizona, United States
- Advanced Clinical Therapeutics — Tucson, Arizona, United States
- First Care Family Doctors — Fayetteville, Arkansas, United States
- CAVHS — Little Rock, Arkansas, United States
- Physicians Group Research Clinic, LLC — Little Rock, Arkansas, United States
- Advanced Clinical Research Institute — Anaheim, California, United States
- Endocrine Metabolic Medical Center — Atherton, California, United States
- Mitchell Research Group, Inc. — Bakersfield, California, United States
- William Zigrang, M.D. — Burlingame, California, United States
- International Clinical Research Network — Chula Vista, California, United States
- Arrowhead Regional Medical Center — Colton, California, United States
- East Bay Clinical Trial Center — Concord, California, United States
- Medical Group of Encino — Encino, California, United States
- Pinnacle Research Group — Anniston, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.